Department of Radiology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Department of Radiology, Fujimi Kogen Hospital, 11100 Ochiai, Fujimi-Cho, Suwa-Gun, 399-0214, Japan.
Abdom Radiol (NY). 2024 Apr;49(4):1264-1274. doi: 10.1007/s00261-024-04186-y. Epub 2024 Feb 23.
This study aims to evaluate and identify magnetic resonance (MR) findings of mural nodules to detect squamous cell carcinoma arising from ovarian mature cystic teratoma (SCC-MCT).
This retrospective study examined 135 patients (SCC-MCTs, n = 12; and benign MCTs, n = 123) with confirmed diagnoses across five different institutions between January 2010 and June 2022. Preoperative MR images for each patient were independently assessed by two experienced radiologists and analyzed following previously reported findings (PRFs): age, tumor size, presence of mural nodules, size of mural nodule, and the angle between mural nodule and cyst wall (acute or obtuse). Furthermore, this study evaluated four mural nodule features-diffusion restriction, fat intensity, Palm tree appearance, and calcification-and the presence of transmural extension.
There were significant differences between the SCC-MCT and benign MCT groups in terms of all PRFs and all mural nodule findings (p < 0.01). Among the PRFs, "tumor size" demonstrated the highest diagnostic performance, with a sensitivity of 83.3% and a specificity of 88.6%. A combination of the aforementioned four mural nodule findings showed a sensitivity and specificity of 83.3% and 97.6%, respectively, for the diagnosis of SCC-MCT. Regarding diagnosis based on a combination of four mural nodule findings, the specificity was significantly higher than the diagnosis based on tumor size (p = 0.021). Based on these mural nodule findings, three SCC-MCT patients without transmural invasion could be diagnosed.
Mural nodule MR findings had a higher diagnostic performance than PRFs for SCC-MCT and can potentially allow early detection of SCC-MCTs.
本研究旨在评估和识别壁结节的磁共振(MR)表现,以检测源自卵巢成熟囊性畸胎瘤(SCC-MCT)的鳞状细胞癌。
本回顾性研究共纳入了 2010 年 1 月至 2022 年 6 月期间在五家不同机构确诊的 135 名患者(SCC-MCT 组,n=12;良性 MCT 组,n=123)。对每位患者的术前 MR 图像由两位有经验的放射科医生进行独立评估,并按照先前报道的发现(PRFs)进行分析:年龄、肿瘤大小、壁结节的存在、壁结节的大小以及壁结节与囊壁之间的角度(锐角或钝角)。此外,本研究评估了壁结节的四个特征-弥散受限、脂肪信号强度、棕榈树征和钙化-以及壁内侵犯的存在。
在所有 PRFs 和所有壁结节发现方面,SCC-MCT 组与良性 MCT 组之间存在显著差异(p<0.01)。在 PRFs 中,“肿瘤大小”的诊断性能最高,敏感性为 83.3%,特异性为 88.6%。上述四个壁结节发现的组合对 SCC-MCT 的诊断具有 83.3%的敏感性和 97.6%的特异性。关于基于四个壁结节发现的组合的诊断,特异性明显高于基于肿瘤大小的诊断(p=0.021)。基于这些壁结节发现,三名无壁内侵犯的 SCC-MCT 患者可以得到诊断。
壁结节 MR 表现对 SCC-MCT 的诊断性能优于 PRFs,并且可能有助于早期发现 SCC-MCT。